Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis

Cardiovascular Research

Volumn 102, Issue 3, 2014, Pages 448-459

  Wang, Pei ^a   Xu, Tian Ying ^a   Guan, Yun Feng ^a   Zhao, Yan ^a   Li, Zhi Yong ^a   Lan, Xiao Hong ^a   Wang, Xia ^a   Yang, Peng Yuan ^a   Kang, Zhi Min ^a   Vanhoutte, Paul M ^a,b   Miao, Chao Yu ^a,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

Apoptosis; Atherosclerosis; Hypothyroidism; Metabolic cardiovascular disease; Thyroid hormone receptor; Vascular smooth muscle cell

Indexed keywords

APOLIPOPROTEIN E; CASPASE 3; JANUS KINASE; LIOTHYRONINE; PROPYLTHIOURACIL; THYROID HORMONE RECEPTOR ALPHA; THYROID HORMONE RECEPTOR BETA; THYROXINE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HYPOTHYROID ATHEROSCLEROSIS; HYPOTHYROIDISM; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SUPPLEMENTATION; THYROIDECTOMY; VASCULAR SMOOTH MUSCLE; ANIMAL; C57BL MOUSE; CELL CULTURE; COMPLICATION; DEFICIENCY; DRUG EFFECTS; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; CELLS, CULTURED; HYPOTHYROIDISM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROPYLTHIOURACIL; RATS; RATS, SPRAGUE-DAWLEY; THYROID HORMONE RECEPTORS ALPHA; THYROID HORMONE RECEPTORS BETA; THYROID HORMONES;

EID: 84901405427     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu056     Document Type: Article

References (43)

1. Weber C, Noels H. Atherosclerosis: Current pathogenesis and therapeutic options. Nat Med 2011;17: 1410-1422.
2. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32.
3. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473: 317-325.
4. Vanhoutte PM. Endothelial dysfunction: The first step toward coronary arteriosclerosis. Circ J 2009;73: 595-601.
5. Forstermann U, Sessa WC. Nitric oxide synthases: Regulation and function. Eur Heart J 2012;33: 829-837. 837a-837d.
6. Thvilum M, Brandt F, Brix TH, Hegedus L. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol 2012;8: 417-424.
7. Cooper DS, Biondi B. Subclinical thyroid disease. Lancet 2012;379: 1142-1154.
8. Tseng FY, LinWY, Lin CC, Lee LT, Li TC, Sung PK, Huang KC. Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults. J Am Coll Cardiol 2012;60: 730-737.
9. Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol 2010;52: 151-156.
10. Squizzato A, Gerdes VE, Brandjes DP, Buller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005;36: 2302-2310.
11. Steiner A, Kendall FE. Atherosclerosis and arteriosclerosis in dogs following ingestion of cholesterol and thiouracil. Arch Pathol (Chic) 1946;42: 433-444.
12. Andrus SB, Fillios LC, Mann GV, Stare FJ. Experimental production of gross atherosclerosis in the rat. J Exp Med 1956;104: 539-554.
13. Creech O Jr, Jordan GL Jr, De Bakey ME, Overton RC, Halpert B. The effect of chronic hypercholesterolemia on canine aortic transplants. Surg Gynecol Obstet 1955;101: 607-614.
14. Gillman J, Gilbert C. Atherosis in the baboon (Papio ursinus); its pathogenesis and etiology. Exp Med Surg 1957;15: 181-221.
15. Kavurma MM, Bhindi R, Lowe HC, Chesterman C, Khachigian LM. Vessel wall apoptosis and atherosclerotic plaque instability. J Thromb Haemost 2005;3: 465-472.
16. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR. Apoptosis of vascular smoothmuscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006;12: 1075-1080.
17. Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J, Bennett M. Vascular smooth muscle cell sirtuin 1 protects againstDNAdamage and inhibits atherosclerosis. Circulation 2013; 127: 386-396.
18. Go MF, Schonfeld G, Pfleger B, Cole TG, Sussman NL, Alpers DH. Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding. J Clin Invest 1988;81: 1615-1620.
19. Grieve DJ, Fletcher S, Pitsillides AA, Botham KM, Elliott J. Effects of oral propylthiouracil treatment on nitric oxide production in rat aorta. Br J Pharmacol 1999;127: 1-8.
20. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, George S, Jackson C. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: Model characterization and effects of pravastatin treatment. Circulation 2005; 111: 1422-1430.
21. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more important than blood pressure level in determination of end-organ damage in rats. J Hypertens 2006; 24: 1125-1135.
22. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: Role of nicotinamidemononucleotide. Cardiovasc Res 2009;81: 370-380.
23. McKinney B, Riley M. An orcein-oil redOstain for concomitant demonstration of elastic tissue and lipid. Stain Technol 1967;42: 245-248.
24. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, Ohashi J, Yada T, Yanagihara N, Shimokawa H. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 2008;205: 2053-2063.
25. Wang P, Xu TY, Guan YF, TianWW, Viollet B, Rui YC, ZhaiQW, SuDF, Miao CY. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 2011;69: 360-374.
26. Wang P, Zhang RY, Song J, Guan YF, Xu TY, Du H, Viollet B, Miao CY. Loss of AMP-activated protein kinase-alpha2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes 2012;61: 1051-1061.
27. Wojcicki J, Samochowiec L, Jaworska M, Hinek A. A search for a model of experimental atherosclerosis: Comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol Pharm 1985;37: 11-21.
28. Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, Brambilla C, Brambilla E. In situ apoptotic cell labeling by the TUNEL method: Improvement and evaluation on cell preparations. J Histochem Cytochem 1996;44: 959-968.
29. Bai B, Liang Y, Xu C, Lee MY, Xu A, Wu D, Vanhoutte PM, Wang Y. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation 2012;126: 729-740.
30. Wang YX, Halks-Miller M, Vergona R, Sullivan ME, Fitch R, Mallari C, Martin-McNulty B, da Cunha V, Freay A, Rubanyi GM, Kauser K. Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 2000;278: H428-H434.
31. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48: 749-762.
32. Baxter JD, Webb P. Thyroid hormone mimetics: Potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov 2009;8: 308-320.
33. Mya MM, Aronow WS. Subclinical hypothyroidism is associated with coronary artery disease in older persons. J Gerontol A Biol Sci Med Sci 2002;57: M658-M659.
34. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med 2000;132: 270-278.
35. John S, DrobnikW, Lackner K, Schmieder RE. Soluble thrombomodulin and endothelial dysfunction in early atherosclerosis. Lancet 1999;354: 1647.
36. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340: 1111-1115.
37. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28: 812-819.
38. Chen WJ, HoWJ, Chang GJ, Chen ST, Pang JH, ChouSH, Tsay PK, KuoCT. Propylthiouracil, independent of its antithyroid effect, produces endothelium-dependent vasodilatation through induction of nitric oxide bioactivity. Atherosclerosis 2008;196: 383-390.
39. Savinova OV, Liu Y, Aasen GA, Mao K, Weltman NY, Nedich BL, Liang Q, Gerdes AM. Thyroid hormone promotes remodeling of coronary resistance vessels. PLoS One 2011; 6: E25054.
40. Cortes C, Eugenin E, Aliaga E, Carreno LJ, Bueno SM, Gonzalez PA, Gayol S, Naranjo D, Noches V, Marassi MP, Rosenthal D, Jadue C, Ibarra P, Keitel C, Wohllk N, Court F, Kalergis AM, Riedel CA. Hypothyroidism in the adult rat causes incremental changes in brain-derived neurotrophic factor, neuronal and astrocyte apoptosis, gliosis, and deterioration of postsynaptic density. Thyroid 2012;22: 951-963.
41. Lopez-Fontal R, Zeini M, Traves PG, Gomez-Ferreria M, Aranda A, Saez GT, Cerda C, Martin-Sanz P, Hortelano S, Bosca L. Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy. PLoS One 2010;5: E8710.
42. Lopez-Fontana CM, Sasso CV, Maselli ME, Santiano FE, Semino SN, Cuello Carrion FD, Jahn GA, Caron RW. Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors. Oncol Rep 2013;30: 1651-1660.
43. O'Brien T, Dinneen SF, O'Brien PC, Palumbo PJ. Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 1993;68: 860-866.